Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...
Sandoz, the Swiss drugmaker, aims to double its annual net sales by 2035, focusing on biosimilars. The company plans to ...
Bristol Myers Squibb announces its experimental cell therapy, arlocabtagene autoleucel, met key goals in a mid-stage trial ...
Lupin Limited has received marketing approval for its biosimilar pegfilgrastim in India, aiding in chemotherapy recovery. The ...
The US health department has officially appointed Michael Davis and Karim Mikhail as permanent heads of the FDA’s drug and ...
Amgen's Imdelltra combined with AstraZeneca's Imfinzi shows significant improvement in overall and progression-free survival ...
In a significant ruling, the Supreme Court of India has dismissed Sanofi's petition against a CBI complaint involving alleged ...
Roivant's experimental drug mosliciguat has demonstrated significant efficacy in treating pulmonary hypertension linked to ...
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...
Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...
Mumbai: Aurobindo Pharma said its wholly owned subsidiary, Lannett Company, has commercially launched a generic version of the asthma treatment 'Advair Diskus' in the US. The drug, a bioequivalent of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results